Sponsored content
sponsored content
Get The Weekend Point of View Newsletter
Top Canadian political and policy opinion and analysis. Saturdays and Sundays. Weekends.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
FOLLOW THE HILL TIMES:
Want to make sure your whole office has the full Hill Times experience?
We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.
More Opinion
Related Stories
- At this pivotal moment, Canada has the ability not only to redefine its healthcare landscape, but also to lead globally in the sector
- At this pivotal moment, Canada has the ability not only to redefine its healthcare landscape, but also to lead globally in the sector
- If Canada were to deploy pharmacogenetic-guided treatments for patients with depression, we would save on average $3,000 per patient. If only 50 per cent of the 1.6 million Canadians with depression were treated based on this method, we would save $2.4-billion per year.
- If Canada were to deploy pharmacogenetic-guided treatments for patients with depression, we would save on average $3,000 per patient. If only 50 per cent of the 1.6 million Canadians with depression were treated based on this method, we would save $2.4-billion per year.
- With continued support, HDTs have the potential to become an important tool in both pandemic preparedness and biodefence for Canada and our global partners.
- With continued support, HDTs have the potential to become an important tool in both pandemic preparedness and biodefence for Canada and our global partners.
- One of the lesser known yet critical issues arising from the disease is its potential effect on drug response and the risk of adverse drug effects.
- One of the lesser known yet critical issues arising from the disease is its potential effect on drug response and the risk of adverse drug effects.
- Politics
- Foreign Policy
- Lobbying
- Legislation
- Policy Briefings
- Politics This Morning
- Hill Climbers
- Civil Circles
- Heard On The Hill
- Election
- Finance and Budget
- Public Service
- Exclusive Lists
- Parliamentary Calendar
- Top 100 Lists and Exclusive Features
- Podcasts
- This Week's Paper
- Search
- Archives
- Digital Newspaper Archives
- Politics
- Foreign Policy
- Lobbying
- Legislation
- Policy Briefings
- Politics This Morning
- Hill Climbers
- Civil Circles
- Heard On The Hill
- Election
- Finance and Budget
- Public Service
- Exclusive Lists
- Parliamentary Calendar
- Top 100 Lists and Exclusive Features
- Podcasts
- This Week's Paper
- Search
- Archives
- Digital Newspaper Archives
-
Get free news updates